Arcus Biosciences (RCUS) EBITDA (2017 - 2026)
Arcus Biosciences' EBITDA came in at -$93 million for Q2 2026, compared with -$6 million a year earlier.
Powered by 
Analysis
Arcus Biosciences (RCUS) EBITDA (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arcus Biosciences reported EBITDA of -$476 million; for FY2025, it came in at -$376 million.
- Going back by year, EBITDA was -$320 million in FY2024, -$332 million in FY2023, -$274 million in FY2022 and $58 million in FY2021.
- The five-year range for quarterly EBITDA is -$140 million (Q3 2025) to $282.44 million (Q4 2021).
- Business Quant data shows RCUS's EBITDA at -$132 million (Q1 2026), -$111 million (Q4 2025) and -$140 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.17 Bn | 1,102.76 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 615.84 Bn | 534.36 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 500.69 Bn | 473.80 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 367.34 Bn | 321.72 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.61 Bn | 261.60 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.75 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 235.51 Bn | 190.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.60 Bn | 164.80 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 169.37 Bn | 116.02 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Arcus Biosciences | 2.60 Bn | -734.34 Mn | - | -93.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -93.00 Mn |
| Mar 31, 2026 | -132.00 Mn |
| Dec 31, 2025 | -111.00 Mn |
| Sep 30, 2025 | -140.00 Mn |
| Jun 30, 2025 | -6.00 Mn |
| Mar 31, 2025 | -119.00 Mn |
| Dec 31, 2024 | -100.00 Mn |
| Sep 30, 2024 | -103.00 Mn |
| Jun 30, 2024 | -104.00 Mn |
| Mar 31, 2024 | -13.00 Mn |
| Dec 31, 2023 | -88.00 Mn |
| Sep 30, 2023 | -79.00 Mn |
| Jun 30, 2023 | -81.00 Mn |
| Mar 31, 2023 | -84.00 Mn |
| Dec 31, 2022 | -73.00 Mn |
| Sep 30, 2022 | -68.00 Mn |
| Jun 30, 2022 | -67.00 Mn |
| Mar 31, 2022 | -66.00 Mn |
| Dec 31, 2021 | 282.44 Mn |
| Sep 30, 2021 | -77.17 Mn |
API Access
Arcus Biosciences EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();